CRCP
RDY icon

Copper Rock Capital Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Copper Rock Capital Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,750
Closed -$59K – 194
2014
Q1 		$59K Buy
+6,750
New +$58.7K 0.01% 202

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Copper Rock Capital Partners's RDY Position: Q2 2014 in Review

Copper Rock Capital Partners sold out of Dr. Reddy's Laboratories (RDY) in Q2 2014, closing a stake of 6,750 shares — an estimated $59K sold.

Copper Rock Capital Partners first reported a position in RDY in Q1 2014 and held it in 1 quarter. The position peaked at $59K in Q1 2014. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2014.

  • Copper Rock Capital Partners reported no remaining Dr. Reddy's Laboratories position as of Q2 2014 after selling out during the quarter.
  • Copper Rock Capital Partners sold 6,750 Dr. Reddy's Laboratories shares in Q2 2014, an estimated $59K.
  • Copper Rock Capital Partners first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 1 quarter.
  • Copper Rock Capital Partners's Dr. Reddy's Laboratories position peaked at $59K in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2014.

Based on Copper Rock Capital Partners's 13F filing for Q2 2014, filed 8 Jul 2014.